These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 20450653
1. [The effect of carvedilol on coronary flow reserve in patients with dilated cardiomyopathy]. Fan Y, Lin JH, Dong G, Zhu J, Yin F, Yang SS. Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):217-9. PubMed ID: 20450653 [Abstract] [Full Text] [Related]
2. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy. Sugioka K, Hozumi T, Takemoto Y, Ehara S, Ogawa K, Iwata S, Oe H, Matsumura Y, Otsuka R, Yoshiyama M, Yoshikawa J. Am Heart J; 2007 Jun; 153(6):1080.e1-6. PubMed ID: 17540213 [Abstract] [Full Text] [Related]
7. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment. Paraskevaidis I, Farmakis D, Parissis JT, Dodouras T, Filippatos G, Tsiapras D, Kremastinos DT. J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050 [Abstract] [Full Text] [Related]
9. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy. Neglia D, De Maria R, Masi S, Gallopin M, Pisani P, Pardini S, Gavazzi A, L'abbate A, Parodi O. Heart; 2007 Jul; 93(7):808-13. PubMed ID: 17237134 [Abstract] [Full Text] [Related]
11. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. Di Lenarda A, Sabbadini G, Salvatore L, Sinagra G, Mestroni L, Pinamonti B, Gregori D, Ciani F, Muzzi A, Klugmann S, Camerini F. J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195 [Abstract] [Full Text] [Related]
12. Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: an echocardiographic study. Santagata P, Rigo F, Gherardi S, Pratali L, Drozdz J, Varga A, Picano E. Int J Cardiol; 2005 Oct 20; 105(1):46-52. PubMed ID: 16207544 [Abstract] [Full Text] [Related]
13. Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study. Sugioka K, Hozumi T, Takemoto Y, Ujino K, Matsumura Y, Watanabe H, Fujimoto K, Yoshiyama M, Yoshikawa J. J Am Coll Cardiol; 2005 Jan 18; 45(2):318-9. PubMed ID: 15653035 [No Abstract] [Full Text] [Related]
15. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy. Naya M, Tsukamoto T, Morita K, Katoh C, Nishijima K, Komatsu H, Yamada S, Kuge Y, Tamaki N, Tsutsui H. J Nucl Med; 2009 Feb 18; 50(2):220-5. PubMed ID: 19164238 [Abstract] [Full Text] [Related]
17. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Tatli E, Kurum T. Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561 [Abstract] [Full Text] [Related]